medigraphic.com
Colegio de Medicina Interna de México.

2006, Number 5

<< Back Next >>

Med Int Mex 2006; 22 (5)

Cavitary pulmonary sporotrichosis: diagnosis and treatment

Carrada BT

Language: Spanish
References: 27
Page: 457-461
PDF size: 324.67 Kb.


ABSTRACT

A 42-year-old male with primary pulmonary sporotrichosis, the diagnosis was confirmed by culture of Sporothrix schenckii in the bronchoalveolar lavage sample, the patient had no dermatologic manifestation. The small number of cases with pulmonary involvement has prevented prospective clinical trials, to determine optimal therapy. The physician’s ability to prescribe the best treatment is limited by the scarce published experience with the use of the azole- drugs and low efficacy reported with older therapies. Oral itraconazol is recommended for patiens with non-life-threating pulmonary sporotricosis, while amphotericin-B is indicated for extensive pulmonary lesions. Surgical removal of infected lung tissue along itraconazol therapy appears to be the most effective treatment.


REFERENCES

  1. Bonifaz A. Micología Médica Básica. México: Méndez-Cervantes, 1990;pp:167-86.

  2. Arenas R. Micología Médica Ilustrada. Clínica, Laboratorio y Terapéutica. México: Interamericana McGraw-Hill, 1993;pp:145-51, 177-83.

  3. Davies SF. An overview of pulmonary fungal infections. Clin Chest Med 1987;8:495-512.

  4. Gatti F, de Vroey C, eds. Human Mycosis in Tropical Countries. 2ª ed. Bologna, Italia: Pub Assoc Ital “Amicidi R Follereau”, OCSI. 1991;pp:161-261.

  5. Jay SJ, Platt MR, Reynolds RC. Primary pulmonary sporotrichosis. Am Rev Resp Dis 1977;115:1051-56.

  6. England DM, Hohholzer L. Primary pulmonary sporotrichosis: Report of eight cases with clinicopathologic review. Am J Surg Pathol 1985;9:193-204.

  7. Watts JC, Chandler FW. Primary pulmonary sporotrichosis. Arch Pathol Lab Med 1987;111:215-7.

  8. Conti- Diaz IA. Epidemiology of sporotrichosis in Latin America. Mycopathologia 1989;108:113-6.

  9. Plus Jl, Opal SM. Pulmonary sporotrichosis: review of treatment and outcome. Medicine 1986;65:143-53.

  10. Gerding DN. Treatment of pulmonary sporotrichosis. Semin Respir Infect 1986;1:61-65.

  11. Breeling JL, Weinstein L. Pulmonary sporotrichosis treated with itraconazole. Chest 1993;103:313-4.

  12. Sharkey-Mathis PK, Kauffman CA, Graybill JR, et al. Treatment of sporotrichosis with itraconazole. Am J Med 1993;95:279-85.

  13. Dall L, Salzman I. Treatment of pulmonary sporotrichosis with Ketoconazole. Rev Infect Dis 1987;9:795-8.

  14. Winn RE, Anderson J, Piper J, et al. Systemic sporotrichosis treated with itraconazole. Clin Infect Dis 1993;17:210-17.

  15. Bolao F, Podzamczer D, Ventin M, et al. Efficacy of acute phase and maintenance therapy with itraconazole in an AIDS patient with sporotrichosis. Eur J Clin Microbiol Infect Dis 1994;13:609-12.

  16. Heller HM, Fuhrer J. Disseminated sporotrichosis in patiens with AIDS: case report and review of the literature. AIDS 1991;5:1243-6.

  17. Rohatgi PK. Pulmonary sporotrichosis. S Med J 1980;73:1611-7.

  18. Fields CL, Ossorio MA, Roy TM. Empyema associated with pulmonary sporotrichosis. S Med J 1989; 82: 910-13.

  19. Parker JD, Sarosi GA, Tosh FE. Treatment of extracutaneous sporotrichosis. Arch Intern Med 1970;125:858-63.

  20. Baker JH, Goodpasture HC, Kuhns HR, et al. Fungemia caused by an amphotericin-B resistant isolate of Sporothrix schenckii. Arch Pathol Lab Med 1989; 113:1279-81.

  21. Ramírez J, Roy TM. Chronic cavity pulmonary sporotrichosis: Efficacy of oral itraconazole. Kentucky Med 1998;96:103-5.

  22. Franzot SP, Hamdan JS. Effects of three azole derivatives on the lipids of different strains of Cryptococcus neoformans. Mycoses. 1995;38:183-9.

  23. Kauffman CA, Pappas PG, Mckinsey DS, et al. Treatment of lymphocutaneus and visceral sporotrichosis with fluconazole. Clin Infect Dis 1996;22:46-50.

  24. Kauffman CA. Old and new therapies for sporotrichosis. Clin Infect Dis 1995;21:981-5.

  25. Restrepo A, Robledo J, Gomez I, Gomez I, et al. Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. Arch Dermatol 1986;122:413-7.

  26. Lavalle P, Suchil P, De Ovando F, et al. Itraconazole for deep mycoses: preliminary experience in Mexico. Rev Infect Dis 1987;9:64-70.

  27. Borelli DL. A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis. Rev Infect Dis 1987;9:57-63.




2020     |     www.medigraphic.com